Drugs / Piracetam
Piracetam
also known as
2-oxo-pyrrolidone · CL-871 · Gabacet · Myocalm · Nootrop · Nootrop 1200 · Nootrop 400 · Nootrop 800 · +2 more
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT00000198 | Oct 1996 → Oct 1997 | cocaine dependence | University of Pennsylvania | Completed | No outcome recorded |
| Phase 1 | NCT00000199 | — | substance-related disorder | University of Pennsylvania | Withdrawn | No outcome recorded |
| Phase 33 trials · 1 met primary | ||||||
| Phase 3 | NCT02374567 | Jan 2015 → Jun 2017 | anxiety disorder, dementia, depressive disorder, schizophrenia +1 | Hannover Medical School | Terminated | No outcome recorded |
| Phase 3 | NCT00190008 | Aug 2003 → ? | tardive dyskinesia | Beersheva Mental Health Center | Completed | Met primary |
| Phase 3 | NCT01549847 | ? → Feb 2013 | postpoliomyelitis syndrome | Biolab Sanus Farmaceutica | Withdrawn | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT05918341 | Jul → Sep 2023 | — | The Netherlands Cancer Institute | Unknown | No outcome recorded |
| Phase 4 | NCT01883011 | Aug 1998 → Jul 2001 | middle cerebral artery infarction | UCB Pharma | Terminated | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00567060 | May 2000 → Jan 2004 | cognitive disorder | UCB Pharma | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT06479629 Comparator | Feb → Nov 2025 overdue | diabetic polyneuropathy | Ain Shams University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT01890538 Comparator | Jun 2013 → May 2014 | peripheral vertigo | Kocaeli University | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2024-11-05 | Advanz Pharma | ADVANZ PHARMA acquires the rights to Nootropil® and Atarax® from UCB for Europe and selected countries in LATAM and APAC advanzpharma.com ↗ |
Evidence & citations 13 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | piracetam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01549847 ↗ |
| Known as | 2-oxo-pyrrolidone | “Piracetam (2-oxo-pyrrolidone) is a nootropic drug structurally related to GABA.” NCT00190008 ↗ |
| Known as | CL-871 | ChEMBL registry synonym — accepted as the source's own label CHEMBL36715 ↗ |
| Known as | Gabacet | ChEMBL registry synonym — accepted as the source's own label CHEMBL36715 ↗ |
| Known as | Myocalm | ChEMBL registry synonym — accepted as the source's own label CHEMBL36715 ↗ |
| Known as | Nootrop | ChEMBL registry synonym — accepted as the source's own label CHEMBL36715 ↗ |
| Known as | Nootrop 1200 | ChEMBL registry synonym — accepted as the source's own label CHEMBL36715 ↗ |
| Known as | Nootrop 400 | ChEMBL registry synonym — accepted as the source's own label CHEMBL36715 ↗ |
| Known as | Nootrop 800 | ChEMBL registry synonym — accepted as the source's own label CHEMBL36715 ↗ |
| Known as | Nootropil | ChEMBL registry synonym — accepted as the source's own label CHEMBL36715 ↗ |
| Known as | NSC-758191 | ChEMBL registry synonym — accepted as the source's own label CHEMBL36715 ↗ |
| Modality | Small molecule | — CHEMBL36715 ↗ |
| Route | Oral | “using an oral preparation” PMID 17685739 ↗ Jul 2007 |